JP Morgan Chase’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-70,000
Closed -$1.2M 7817
2023
Q3
$1.2M Buy
+70,000
New +$1.37M ﹤0.01% 3936

Other funds holding REPL

JP Morgan Chase's REPL Position: Q1 2026 in Review

JP Morgan Chase reduced its Replimune Group (REPL) stake by 15% in Q1 2026, selling an estimated $1.03M and leaving 789,951 shares worth $5.69M. The position accounts for ﹤0.01% of the portfolio, ranked #3208.

JP Morgan Chase first reported a position in REPL in Q3 2018 and has held it in 31 quarters since. The position peaked at $13.4M in Q2 2021. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • JP Morgan Chase held 789,951 shares of Replimune Group worth $5.69M as of Q1 2026.
  • JP Morgan Chase sold 135,222 Replimune Group shares in Q1 2026, an estimated $1.03M.
  • Replimune Group made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3208 holding.
  • JP Morgan Chase first reported a position in Replimune Group in Q3 2018 and has held it in 31 quarters since.
  • JP Morgan Chase's Replimune Group position peaked at $13.4M in Q2 2021.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.